SEC Form 4 · accession 0001213900-15-001603
Icagen, Inc. · ICGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Palmieri
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 6, 2015 · 11:58 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001518520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2015 | J | 10,000 | $0.01 | A | 106,615 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.01 | Mar 3, 2015 | X | 10,000 | D | May 3, 2013 | May 3, 2020 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Warrants were received as compensation for advisory services provided to XRpro Sciences, Inc. (the "Company") in connection with the Company's issuance of securities in a private placement. The warrants were exercised in full by the reporting person on March 3, 2015.